ClinicalTrials.govpublic full text
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
hpv-associated oropharyngeal squamous cell carcinoma, hpv positive oropharyngeal squamous cell carcinoma, hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 stage, hpv-related squamous cell carcinoma, clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, pathologic stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, pathologic stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, pathologic stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 clinical stage, hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 pathologic stage
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 992124
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.